News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
219,290 Results
Type
Article (18295)
Company Profile (160)
Press Release (200835)
Section
Business (62111)
Career Advice (195)
Deals (9053)
Drug Delivery (52)
Drug Development (34080)
Employer Resources (33)
FDA (6756)
Job Trends (6256)
News (112747)
Policy (11372)
Tag
Academia (1579)
Alliances (17758)
Alzheimer's disease (522)
Approvals (6739)
Artificial intelligence (70)
Bankruptcy (51)
Best Places to Work (5917)
Biosimilars (38)
Biotechnology (119)
Breast cancer (59)
Cancer (525)
Cardiovascular disease (53)
Career advice (175)
CAR-T (38)
Cell therapy (114)
Clinical research (27610)
Collaboration (213)
Compensation (73)
COVID-19 (1065)
C-suite (55)
Cystic fibrosis (47)
Data (645)
Diabetes (80)
Diagnostics (2125)
Drug pricing (47)
Earnings (18471)
Events (32339)
Executive appointments (159)
FDA (7027)
Funding (142)
Gene editing (48)
Gene therapy (111)
GLP-1 (327)
Government (1582)
Healthcare (7640)
Infectious disease (1106)
Inflammatory bowel disease (78)
IPO (4324)
Job creations (720)
Job search strategy (167)
Layoffs (117)
Legal (1797)
Lung cancer (82)
Manufacturing (75)
Medical device (2554)
Medtech (2555)
Mergers & acquisitions (4804)
Metabolic disorders (227)
Neuroscience (643)
NextGen Class of 2024 (2126)
Non-profit (1698)
Northern California (690)
Obesity (144)
Opinion (65)
People (21931)
Phase I (7620)
Phase II (11168)
Phase III (10810)
Pipeline (216)
Postmarket research (1434)
Preclinical (3057)
Radiopharmaceuticals (138)
Rare diseases (126)
Real estate (1554)
Regulatory (8636)
Research institute (1347)
Southern California (525)
Startups (1360)
United States (5793)
Vaccines (232)
Weight loss (93)
Date
Today (1)
Last 7 days (294)
Last 30 days (1511)
Last 365 days (15738)
2024 (14404)
2023 (16862)
2022 (21074)
2021 (21885)
2020 (20061)
2019 (17198)
2018 (12921)
2017 (12128)
2016 (11282)
2015 (12157)
2014 (8508)
2013 (7012)
2012 (7081)
2011 (7056)
2010 (5731)
Location
Africa (232)
Asia (15188)
Australia (2063)
California (1433)
Canada (401)
China (129)
Colorado (52)
Connecticut (82)
Delaware (45)
Europe (32791)
Florida (200)
Georgia (38)
Illinois (134)
Indiana (114)
Japan (53)
Maryland (188)
Massachusetts (1279)
Minnesota (50)
New Jersey (535)
New York (419)
North Carolina (342)
Northern California (690)
Ohio (57)
Pennsylvania (321)
South America (294)
Southern California (525)
Texas (144)
Utah (45)
Washington State (186)
219,290 Results for "hua medicine".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hua Medicine’s Leadership in Diabetes Treatment Recognized: CEO Dr. Li CHEN Awarded Prestigious C.C. Tan Life Science Industrialization Award
November 5, 2024
·
2 min read
Press Releases
Founder of Hua Medicine Dr. Li CHEN was awarded the “C.C. Tan Life Science Industrialization Award”
October 24, 2024
·
4 min read
Drug Development
HUADONG MEDICINE Announces Positive Phase I Results for Innovative Oral Small Molecule GLP-1 Receptor Agonist HDM1002
HUADONG MEDICINE, through its wholly-owned subsidiary Hangzhou Zhongmei HuaDong Pharmaceutical CO. LTD (Zhongmei HuaDong), has recently announced positive results from Phase I clinical trials of its innovative oral small molecule GLP-1 receptor agonist HDM1002 in China.
June 26, 2024
·
2 min read
Business
Cerus Corporation Announces Appointment of Hua Shan, MD, PhD to Board of Directors
Cerus Corporation announced the appointment of Hua Shan, MD, PhD, Professor of Pathology and Medical Director, Transfusion Medicine Service at Stanford Medical Center to its Board of Directors.
July 5, 2022
·
2 min read
Business
CARsgen Appoints Dr. Hua Jiang as Executive Director
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that Dr. Hua Jiang (“Dr. Jiang”) has been appointed as Executive Director of the Company.
August 2, 2022
·
3 min read
Pancreatic cancer
Revolution Medicines Targets Hard-to-Treat Pancreatic Cancer With Two Early-Phase Readouts
Jefferies analyst Kelly Shi in a Sunday note to investors said that both data drops for Revolution Medicines’ experimental RAS inhibitors are positive and could be “synergistic” in the first-line setting for pancreatic ductal adenocarcinoma.
October 28, 2024
·
2 min read
·
Tristan Manalac
Business
Novartis, Versant Launch RNA Kidney Medicines—Focused Borealis
Looking to build on the success of Chinook Therapeutics, founded by Versant in 2019 and acquired by Novartis last year, the companies on Thursday launched Borealis Biosciences with $150 million in funding to develop RNA therapeutics for kidney diseases.
August 22, 2024
·
2 min read
·
Kate Goodwin
XNK Therapeutics to present at Redeye Regenerative Medicine/Cell Therapy event
XNK Therapeutics AB announced that Johan Liwing, CEO, will present the company at the Redeye Regenerative Medicine/Cell Therapy event on February 14.
February 8, 2024
·
1 min read
Gene Editing
Gene Editor Prime Medicine Signs BMS Cell Therapy Deal, Reprioritizes Pipeline
In an effort to expand its cash runway beyond 12 months, Prime Medicine has signed a deal with Bristol Myers Squibb worth a potential $3.5 billion, while also streamlining its pipeline to trim costs.
September 30, 2024
·
2 min read
·
Annalee Armstrong
Rare Diseases
Biopharma Entrepreneurs Make Business Case for Personalized Genetic Medicines
Experts say the time is now to develop and provide widespread access to genetic medicines for the rarest diseases. What’s more, they say it is a moral imperative.
August 7, 2024
·
6 min read
·
Heather McKenzie
1 of 21,929
Next
